174 related articles for article (PubMed ID: 33705566)
1. Usefulness of microRNA detection in the diagnostics of endometrial cancer.
Donkers H; Hirschfeld M; Weiß D; Erbes T; Jaeger M; Pijnenborg JMA; Bekkers R; Galaal K;
Acta Obstet Gynecol Scand; 2021 Jun; 100(6):1148-1154. PubMed ID: 33705566
[TBL] [Abstract][Full Text] [Related]
2. Association of microRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer.
Wilczynski M; Danielska J; Domanska-Senderowska D; Dzieniecka M; Szymanska B; Malinowski A
Acta Obstet Gynecol Scand; 2018 May; 97(5):560-569. PubMed ID: 29355888
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic potential of differentially regulated microRNAs among endometriosis, endometrioid ovarian cancer, and endometrial cancer.
Kumari P; Sharma I; Saha SC; Srinivasan R; Minhas P
J Cancer Res Ther; 2021; 17(4):1003-1011. PubMed ID: 34528556
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
5. Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma.
Lee H; Choi HJ; Kang CS; Lee HJ; Lee WS; Park CS
Mod Pathol; 2012 Nov; 25(11):1508-15. PubMed ID: 22766795
[TBL] [Abstract][Full Text] [Related]
6. Aberrant microRNA expression in endometrial carcinoma using formalin-fixed paraffin-embedded (FFPE) tissues.
Lee TS; Jeon HW; Kim YB; Kim YA; Kim MA; Kang SB
PLoS One; 2013; 8(12):e81421. PubMed ID: 24363810
[TBL] [Abstract][Full Text] [Related]
7. MiRNAs in endometrioid endometrial cancer metastatic loci derived from positive lymph nodes.
Wilczynski M; Senderowska D; Krawczyk T; Szymanska B; Malinowski A
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1085-1091. PubMed ID: 32100871
[TBL] [Abstract][Full Text] [Related]
8. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
9. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma.
Wu W; Lin Z; Zhuang Z; Liang X
Eur J Cancer Prev; 2009 Feb; 18(1):50-5. PubMed ID: 19077565
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression as a diagnostic parameter in early endometrial cancer.
Blagojević S; Andrić B; Jovankić J; Milutinović M; Nikodijević D; Arsenijević P; Cvetković D
Int J Gynecol Cancer; 2023 Sep; 33(9):1394-1401. PubMed ID: 37541686
[TBL] [Abstract][Full Text] [Related]
11. miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma.
Yoneyama K; Ishibashi O; Kawase R; Kurose K; Takeshita T
Anticancer Res; 2015 Mar; 35(3):1401-10. PubMed ID: 25750291
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive miRNA profiling of surgically staged endometrial cancer.
Cohn DE; Fabbri M; Valeri N; Alder H; Ivanov I; Liu CG; Croce CM; Resnick KE
Am J Obstet Gynecol; 2010 Jun; 202(6):656.e1-8. PubMed ID: 20400061
[TBL] [Abstract][Full Text] [Related]
13. Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma.
Tsukamoto O; Miura K; Mishima H; Abe S; Kaneuchi M; Higashijima A; Miura S; Kinoshita A; Yoshiura K; Masuzaki H
Gynecol Oncol; 2014 Mar; 132(3):715-21. PubMed ID: 24491411
[TBL] [Abstract][Full Text] [Related]
14. Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial Cancer.
Wu X; Han Y; Liu F; Ruan L
J Comput Biol; 2020 May; 27(5):834-844. PubMed ID: 31513434
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
Zhang X; Dong Y; Ti H; Zhao J; Wang Y; Li T; Zhang B
Hum Pathol; 2013 Nov; 44(11):2571-80. PubMed ID: 24071015
[TBL] [Abstract][Full Text] [Related]
16. Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
BMC Cancer; 2012 Aug; 12():369. PubMed ID: 22920721
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in endometrial cancers from black and white patients.
Maxwell GL; Shoji Y; Darcy K; Litzi T; Berchuck A; Hamilton CA; Conrads TP; Risinger JI
Am J Obstet Gynecol; 2015 Feb; 212(2):191.e1-10. PubMed ID: 25174797
[TBL] [Abstract][Full Text] [Related]
18. The microRNA-200 family is upregulated in endometrial carcinoma.
Snowdon J; Zhang X; Childs T; Tron VA; Feilotter H
PLoS One; 2011; 6(8):e22828. PubMed ID: 21897839
[TBL] [Abstract][Full Text] [Related]
19. microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer.
Ramón LA; Braza-Boïls A; Gilabert J; Chirivella M; España F; Estellés A; Gilabert-Estellés J
Hum Reprod; 2012 Oct; 27(10):3036-45. PubMed ID: 22904162
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
